Dental/Medical Diagnostic Systems Inc. Receives $4.0 Million Order for Its Wireless Apollo e and Wavelight Curing Units Based on New LED Technology
Source: DMDS
Woodland Hills, CA. Dental/Medical Diagnostic Systems Inc. (Nasdaq:DMDS) a developer and marketer of high tech dental equipment, today announced that Hakusui Trading Co. Ltd. of Japan has placed a purchase order valued at approximately $4.0 million for its Apollo™ e light and Wavelight e products based upon its new patented, Light Emitting Diode (LED) high speed curing technology. Hakusui is one of Japan s largest distributors of dental supplies and equipment and is already a large international customer of DMDS.
Hakusui has agreed to purchase the Apollo e light and Wavelight e units over the period December 2000 to December 2001. DMDS expects to start shipping this new product by the end of November 2000. This wireless, fast curing light is based on a whole new and extremely efficient light source, namely Light Emitting Diode, or LED. Various authorities worldwide have already mentioned LEDs to be the ultimate light source for activating light cured materials in the future. To achieve sufficient power output for polymerization, DMDS developed a unique, patented lens system enabling the LED technology to produce faster curing.
The main anticipated benefits of the new LED technology are the long and constant life span, the absence of any heat and the potential for future upgrades of the unit by means of the Internet.
Dental/Medical Diagnostic Systems CEO Bob Gurevitch stated, "We are extremely excited about this order from Hakusui Trading Co., for our new, patented LED high-speed curing technology. Hakusui is a major distributor and market leader in Japan. We continue to be encouraged by the response of market leaders to our new curing technology."
Dental/Medical Diagnostic Systems designs, develops, and sells high technology dental equipment and related consumables. Although only founded in 1996, DMDS has quickly become a leader in applying innovative technology for curing dental materials faster and better.
This news release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 ("Securities Act") and Section 21E of the Securities Exchange Act of the 1934 (The "Exchange Act") such as the nature of the new product, timing of release of the product and the ultimate success of the product for its intended uses. Although DMDS believes that the expectations reflected in such forward-looking statements are reasonable at this time, it can give no assurance that such expectations will prove to have been correct. Forward-looking statements involve numerous risks and uncertainties described in DMDS s most recently filed Current Report on Form 8-K, Quarterly Report on Form 10-Q and Annual Report on Form 10-K filed with the Securities and Exchange Commission which should be read in conjunction herewith, copies of which are available from the DMDS s investor relations department. Actual results may differ materially from those contemplated by the forward-looking statements set forth herein. DMDS expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any statement herein or to reflect any change in DMDS s expectations or any change in events, conditions or circumstances on which any such statement is based.
Contact: Dental/Medical Diagnostic Systems Inc., Woodland Hills Robert Gurevitch/Stephen Ross, 818/932-2300 Tel: 818/595-0226 (fax) stever@dmdcorp.com or Coffin Communications Group, Sherman Oaks, Calif. Bill Coffin/Sean Collins Tel: 818/789-0100
Dental/Medical Diagnostic Systems Inc., Woodland HillsRobert Gurevitch/Stephen Ross, 818/932-2300
Tel: 818/595-0226 (fax)
stever@dmdcorp.com
or
Coffin Communications Group, Sherman Oaks, Calif.
Bill Coffin/Sean Collins
Tel: 818/789-0100
E-mail: stever@dmdcorp.com
